T-Cell Large Granular Lymphocyte Leukemia

T-Cell Large Granular Lymphocyte Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

58 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 8
Recruiting: 5
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Institute of Hematology & Blood Diseases Hospital, China
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (14)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05141682	Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia	active not recruiting	Phase 1 / Phase 2	11	Jonathan BrammerOTHER	1	Jul 28, 2026	clinicaltrials
NCT07682792	Golidocitinib in Patients With Mycosis Fungoides/Sézary Syndrome and T-Cell Large Granular Lymphocytic Leukemia(GEMSTONE)	not yet recruiting	Phase 2	24	Washington University School of MedicineOTHER	1	Jul 6, 2026